Recent BioUtah News & Events

Apr 14, 2026 University of Utah Health dedicated the James LeVoy Sorenson Center for Medical Innovation, a $50-million world-class hub designed to accelerate transformative research, medical device development, and life science training. Made possible by a generous $22 million lead gift from the Sorenson Legacy Foundation, the state-of-the-art facility serves as the new heart of […]

James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting

PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

Freyya Selected as Finalist for Tech Fuel 2026

The “White Glove” Delivery: How a Joke Landed Me in Iceland

The Only Pediatric Health Platform Pairing an FDA-Cleared Infant Wearable with a Cybersecurity-Certified Video Monitor Earns Top Recognition from Editors and Expert Testers

Kimbell & Associates offers highlights of President Trump’s FY 2027 Budget Request

By Henry O’Connell, Canary Speech Five years into caring for a patient, a primary care physician saw her again shortly after she delivered her first child. The visit was scheduled as a routine six-week newborn evaluation. As is common in primary care, the encounter extended beyond the infant to include the mother’s well-being. During the […]

Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The University of Utah has been named to the National Academy of Inventors’ (NAI) 2025 Top 100 U.S. Universities Granted U.S. Utility Patents list, further reinforcing its position as a national leader in research, innovation, and commercialization. This […]

SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection […]

First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target many types of cancer Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that the initial biodistribution study […]

TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover NEW ORLEANS–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), demonstrating significant and sustained patient benefits […]

Via OrthoSpineNews   Major clinical milestone marks SINTX’s entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform SALT LAKE CITY, Utah, March 19, 2026 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramic biomaterials and silicon nitride medical device innovation, […]

Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia SALT LAKE CITY, April 2, 2026 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoMira […]

Salt Lake City–based laboratory opens normally restricted space to invited guests, highlighting the behind‑the‑scenes work that helps keep medicines and medical products safe   SALT LAKE CITY (April 1, 2026) — Nelson Labs, a Salt Lake City–founded global leader in laboratory testing services, recently hosted invited guests for a rare look inside a new cleanroom […]

Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient.

BioUtah president & CEO, Kelvyn Cullimoire, was invited by the Korean Health Industry Development Institute (KHIDI), an agency of the Korean Ministry of Health, to present at the Medical Korea conference on March 19-20, 2026. The topic of Cullimore’s presentation was “Why Utah is a preferred landing place for Korean medical device companies desiring to […]

BioUtah CEO, Kelvyn Cullimore, Makes the Rounds in DC

First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease.

Biotech is playing an increasingly important role in U.S. economic competitiveness and national security, and Utah plays a key role in contributing to the strength of the American biotech ecosystem.

The addition of APEXecm reflects Kolosis’s continued commitment to developing and commercializing best-in-class solutions for the surgical community

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the U.S.

New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for patients with esophageal fistulas and malignant strictures

For Fabry patients, a potential path to converting 130 clinic visits into one treatment every five years.

New results demonstrate early VOXZOGO treatment leads to durable and sustained improvements in skeletal growth-related health outcomes, including proportionality, arm span and body mass index, building on over 10,000 patient-years of data  

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)

Women-led companies join Springboard’s accelerator to advance innovation across the women’s health landscape.

Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’

The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation

ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG

Launch Represents Significant Step to Broader Commercialization